BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1956 related articles for article (PubMed ID: 18317216)

  • 1. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
    Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
    Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic image (224). A pregnant woman with vaginal blood loss].
    van Dillen J; van Roosmalen J
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):182. PubMed ID: 15702737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choriocarcinoma following ovarian hydatidiform mole: a case report.
    Joneborg U; Papadogiannakis N; Lindell G; Marions L
    J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester diagnosis of partial mole.
    Phupong V; Triratanachat S; Promchainant C; Ultchaswadi P
    Arch Gynecol Obstet; 2005 Sep; 272(3):235-7. PubMed ID: 15875207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On interrupted postmolar choriocarcinoma].
    Hando T; Kodama S; Takeuchi S; Goto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2019-22. PubMed ID: 4078405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter- and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia.
    Messerli ML; Parmley T; Woodruff JD; Lilienfeld AM; Bevilacqua L; Rosenshein NB
    Obstet Gynecol; 1987 Apr; 69(4):622-6. PubMed ID: 3029643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester diagnosis of a partial mole with the combined use of ultrasound and chorionic villous sampling.
    Romero R; Ghidini A; Sirtori M; Cullen M; Fisher N; Hobbins JC
    Am J Perinatol; 1989 Jul; 6(3):314-5. PubMed ID: 2659011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal complete hydatidiform mole: a case report.
    Abike F; Temizkan O; Payasli A; Avsar F; Karahan N; Baspinar S
    Maturitas; 2008 Jan; 59(1):95-8. PubMed ID: 18162339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
    Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
    Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial hydatidiform mole along with term gestation and alive baby.
    Parveen Z; Bashir R; Jadoon T; Qayum I
    J Ayub Med Coll Abbottabad; 2004; 16(4):84-5. PubMed ID: 15762073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis.
    Jeffers MD; O'Dwyer P; Curran B; Leader M; Gillan JE
    Int J Gynecol Pathol; 1993 Oct; 12(4):315-23. PubMed ID: 8253548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1976 Feb; 47(2):183-8. PubMed ID: 1250540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathologic profile of the partial hydatidiform mole.
    Szulman AE; Surti U
    Obstet Gynecol; 1982 May; 59(5):597-602. PubMed ID: 7070731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of hydatidiform moles.
    Fox H
    Gen Diagn Pathol; 1997 Nov; 143(2-3):117-25. PubMed ID: 9443569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of clinical features in hydatidiform mole: analysis of 113 cases.
    Hou JL; Wan XR; Xiang Y; Qi QW; Yang XY
    J Reprod Med; 2008 Aug; 53(8):629-33. PubMed ID: 18773629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.